Objective: To explain the help of economic analyses in the understanding of lung cancer (LC) management with a description of the quality of selected papers.
Methods: In the first part, quality criteria of economic analyses are depicted with the key words for the literature selection.
Results: The global costs of LC through literature review are depicted; then, in a second part, the costs of each stage of the disease. Finally, costs of chemotherapeutic drugs and target molecules are also discussed.
Conclusion: Economic analyses are unavoidable to assess the burden of the disease but also the cost of each management strategy for LC.